20 May 2024
Biomedicines Webinar | Emerging Trends in Pathophysiology and Therapy of COVID-19, 4 June 2024


Although the worst of the SARS CoV-2 pandemic is behind us, many questions and issues persist. Systemic manifestations due to COVID-19 infections and long COVID continue to emerge in multiple countries. There are a few new USA FDA-approved vaccines available in addition to the Moderna, Pfizer, and Johnson and Johnson ones, but vaccine effectiveness and immunologic memory appear to be limited in most patients. Therapies are available and should be incorporated into treatment plans for COVID-19 patients. Although the focus of these therapies is on hospitalized COVID-19 patients, orally delivered medications are now administered by health care providers.

This webinar will present discussions on these issues, as well as emerging trends, to understand COVID-19 infections and transmissibility more fully.

Date: 4 June 2024 at 5:00 CEST | 11:00 a.m. EDT | 11:00 p.m. CST Asia
Webinar ID: 828 4947 7200
Webinar Secretariat: [email protected]
Webinar Announcement: https://sciforum.net/event/Biomedicines-14

After registering, you will receive a confirmation email containing information on how to join the webinar.
Registrations with academic or institutional email addresses will be prioritized.

Unable to attend? Feel free to still register, and we will inform you when the recording is available.

Register now for free!

Speaker/Presentation

Time in CEST

Time in EDT

Prof. Dr. Jon Suzuki
Chair Introduction
Periodontal Disease Implications for COVID

5:00 p.m.–5:30 p.m.

11:00 a.m.–11:30 p.m.

Dr. Rosalinda Sorrentino
Emerging Trends in Post-COVID-19 Therapy

5:30 p.m.–5:50 p.m.

11:30 a.m.–11:50 p.m.

Prof. Dr. Stefano D’Errico
COVID-19: From Pathophysiology to Therapy: The Leading Role of Autopsy 4 Years After The <<Lockdown of Science>>

5:50 p.m.–6:10 p.m.

11:50 p.m.–12:10 p.m.

Dr. Mariana D’Alessandro
Biological Markers for Pulmonary Fibrosis Sequelae Post-COVID-19 (Part 1)

6:10 p.m.–6:20 p.m.

12:10 p.m.–12:20 p.m.

Dr. Sara Gangi
Biological Markers for Pulmonary Fibrosis Sequelae Post-COVID-19 (Part 2)

6:20 p.m.–6:30 p.m.

12:20 p.m.–12:30 p.m.

Q&A Session

6:30 p.m.–6:45 p.m.

12:30 p.m.–12:45 p.m.

Prof. Dr. Jon Suzuki

Closing of Webinar

6:45 p.m.–6:50 p.m.

12:45 p.m.–12:50 p.m.

Webinar Chair and Keynote Speakers:

  • Jon Suzuki (Chair), 1University of Maryland, USA, 2University of Washington, USA, 3Nova Southeastern University, USA, 4Temple University, USA;
  • Rosalinda Sorrentino, University of Salerno, Italy;
  • Stefano D’Errico, University of Trieste, Italy;
  • Miriana D’Alessandro, University of Siena, Italy;
  • Sara Gangi, University of Siena, Italy.

Relevant Special Issue:
Emerging Trends in Pathophysiology and Therapy of COVID-19
Guest Editors: Dr. Jon Suzuki and Dr. Miriam Ting

Back to TopTop